Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16157892 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C
Condition: Hepatitis C
Intervention: Dietary Supplement: ascorbic acid (vitamin C)
2 Suspended Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
Conditions: Sarcoma;   Adenocarcinoma;   Carcinoma;   Multiple Myeloma;   Desmoplastic Small Round Cell Tumor
Intervention: Drug: Ascorbic acid (vitamin C)

Indicates status has not been verified in more than two years